| Home | Article Database | Fun Stuff | Resources | Tools & Calculators | Search HY


Ask the Mental Health Expert Archives 2001-2004

Expert Home  |  Archives by Date  |  Search Expert Archives  |  For Professionals  |  For Consumers


Bupropion and Venlafaxine

Q. I have a question regarding the coadministration of bupropion and venlafaxine. I am currently on venlafaxine and will subsequently switch to bupropion. I am aware that these are two different systems of reuptake inhibitors: the former, SSRI, and the latter DARI. If I switch solely to bupropion, how will that affect my serotonin and norepinephrine levels? Has there been any known coadministration of SSRIs and atypical antidepressants such as bupropion? How successful is this in the treatment of depression?

A. Venlafaxine [Effexor] is actually a dual-action agent: it increases levels of both serotonin and (to a lesser extent) norepinephrine in the brain. The precise mechanism of action of bupropion [Wellbutrin] is not really well-understood, but it does seem to increase another brain chemical, dopamine, and perhaps also norepinephrine.

So, switching completely from venlafaxine to bupropion would essentially remove the serotonin kick that you are getting with the venlafaxine. This might or might not be helpful for you--a matter to discuss with your doctor. I am not aware of controlled studies using the combination of these agents.

However, there are case reports of successful use of combination therapy, involving combined venlafaxine and bupropion (e.g., Fatemi et al, Ann Pharmacother. 1999 Jun;33(6):701-3). But, bupropion may increase blood levels of venlafaxine, so this would need to be monitored. (High blood levels of venlafaxine may cause high blood pressure in some patients).

For some patients, this particular combination may work synergistically; i.e., better than either agent alone. However, not everyone needs two antidepressants, and you might do just as well on bupropion alone with less expense and fewer side effects. All these questions are best discussed with your prescribing physician.

December 2003

Disclaimer Back to Ask the Expert



 
ADDITIONAL ONLINE RESOURCES FROM CMPMEDICA
Featured Resources > Psychiatry Careers > Today's Practice - Practice Management Resource > Bipolar Depression Infocenter
CancerNetwork > Cancer diagnosis, treatment, and prevention > Podcasts for Oncologists > Cancer Patient Resources > Oncology Areas of Confusion > Oncology News > Cancer Management Handbook > Oncology E-Learning > ASCO Conference Report
Consultant Live > Pediatric Asthma > Practical Clinical Advice > Medical Photoclinic > Diagnosing and Treating H1N1 flu (swine flu) > Primary Care Conference Reports > Community Acquired MRSA
Diagnostic Imaging > Medical Imaging News and Features > Medical Imaging and Radiology White Papers > Radiology Conference Reports > Radiology Special Reports > Radiology Net Seminars > Imaging Trends and Advances > CT Dose Issues and Articles > Molecular Imaging Articles
Psychiatric Times > Psychiatric News and Special Reports > APA Conference Report > Psychiatric Clinical Scales > Psychiatric Times Blog > Psychiatry Career Opportunities > DSM-V
Physicians Practice > Practice Management > EMR Software > Medical Practice Management Software > Medical Buyers Guide > Medical Coding
SearchMedica > Professional Medical Search Engine > Medical Search Tips Newsletter > Medical Search News
CME LLC > Continuing Medical Education > Psychiatry CME > Oncology CME > Practice Management CME > Primary Care CME > Psychiatric Congress > Performance Improvement CME
More Resources > Consumer Healthcare Information > Patient and Caregiver Resource > Search drug information, interactions, images & diagnosis